Jazz Pharmaceuticals (JAZZ) EBIT Margin (2010 - 2026)
Jazz Pharmaceuticals' EBIT Margin was 20.54% in Q2 2026, up 86.18 percentage points from -65.64% a year earlier but down 10.95 percentage points from the prior quarter.
Powered by 
Analysis
Jazz Pharmaceuticals (JAZZ) EBIT Margin (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Jazz Pharmaceuticals' EBIT Margin was 19.49% through Jun 30, 2026, up 26.62 percentage points year-over-year; for FY2025, it came in at -10.08%, down 27.69 percentage points from FY2024.
- EBIT Margin shows a five-year change of -26.08 percentage points (FY2020 to FY2025).
- In earlier years, EBIT Margin was 17.61% in FY2024 (+2.52 pp), 15.09% in FY2023 (+16.88 pp), -1.79% in FY2022 (-7.29 pp) and 5.50% in FY2021 (-10.49 pp).
- Quarterly EBIT Margin has moved between -65.64% (Q2 2025) and 31.49% (Q1 2026) over five years.
- Compared with a year earlier, EBIT Margin has increased for three straight quarters, with an average year-over-year change of +2.72 percentage points over the last eight quarters.
- The best year-over-year quarter for EBIT Margin over five years was Q2 2026 (a gain of 86.18 percentage points); the worst was Q2 2025 (a drop of 85.12 percentage points).
- Per Business Quant data, JAZZ's EBIT Margin in the three quarters before Q2 2026 was 31.49% (Q1 2026), 21.25% (Q4 2025) and 5.11% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Jazz Pharmaceuticals | 15.47 Bn | 9.29 Bn | 1.09 Bn | 20.54% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.54% |
| Mar 31, 2026 | 31.49% |
| Dec 31, 2025 | 21.25% |
| Sep 30, 2025 | 5.11% |
| Jun 30, 2025 | -65.64% |
| Mar 31, 2025 | -6.23% |
| Dec 31, 2024 | 17.53% |
| Sep 30, 2024 | 24.67% |
| Jun 30, 2024 | 19.48% |
| Mar 31, 2024 | 7.34% |
| Dec 31, 2023 | 12.11% |
| Sep 30, 2023 | 17.73% |
| Jun 30, 2023 | 16.47% |
| Mar 31, 2023 | 14.12% |
| Dec 31, 2022 | -27.09% |
| Sep 30, 2022 | 2.63% |
| Jun 30, 2022 | 9.17% |
| Mar 31, 2022 | 10.76% |
| Dec 31, 2021 | 5.51% |
| Sep 30, 2021 | 3.38% |
API Access
Jazz Pharmaceuticals EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=JAZZ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "JAZZ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=JAZZ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();